DNA Methylation in the Malignant Transformation of Meningiomas

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Gao, Fan ^a   Shi, Lingling ^a   Russin, Jonathan ^a   Zeng, Liyun ^a   Chang, Xiao ^a   He, Shuhan ^a   Chen, Thomas C ^a   Giannotta, Steven L ^a   Weisenberger, Daniel J ^a   Zada, Gabriel ^a   Mack, William J ^a   Wang, Kai ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA6; TRANSCRIPTION FACTOR HOXA9; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BINDING SITE; CONTROLLED STUDY; CPG ISLAND; DISEASE MARKER; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAL2 ONCOGENE; MALE; MALIGNANT MENINGIOMA; MALIGNANT TRANSFORMATION; MENINGIOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN BINDING; PROTEIN DNA BINDING;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYCOMB-GROUP PROTEINS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84872808900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054114     Document Type: Article

References (42)

1. Riemenschneider MJ, Perry A, Reifenberger G, (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5: 1045-1054.
2. Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, et al. (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114: 249-256.
3. Perry A, Gutmann DH, Reifenberger G, (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70: 183-202.
4. Mawrin C, Perry A, (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99: 379-391.
5. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC, (1999) "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85: 2046-2056.
6. Dobbins SE, Broderick P, Melin B, Feychting M, Johansen C, et al. (2011) Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 43: 825-827.
7. Lee Y, Liu J, Patel S, Cloughesy T, Lai A, et al. (2010) Genomic landscape of meningiomas. Brain Pathol 20: 751-762.
8. Jones PA, Baylin SB, (2007) The epigenomics of cancer. Cell 128: 683-692.
9. Bird A, (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
10. Adams RL, Burdon RH, (1982) DNA methylation in eukaryotes. CRC Crit Rev Biochem 13: 349-384.
11. Adams RL, Lindsay H, (1993) What is hemimethylated DNA? FEBS Lett 320: 243-245.
12. Antequera F, Bird A, (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A 90: 11995-11999.
13. Larsen F, Gundersen G, Lopez R, Prydz H, (1992) CpG islands as gene markers in the human genome. Genomics 13: 1095-1107.
14. Baylin SB, Makos M, Wu JJ, Yen RW, de Bustros A, et al. (1991) Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 3: 383-390.
15. Bedford MT, van Helden PD, (1987) Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 47: 5274-5276.
16. Diala ES, Cheah MS, Rowitch D, Hoffman RM, (1983) Extent of DNA methylation in human tumor cells. J Natl Cancer Inst 71: 755-764.
17. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M, (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48: 1159-1161.
18. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, et al. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11: 6883-6894.
19. Jones PA, Buckley JD, (1990) The role of DNA methylation in cancer. Adv Cancer Res 54: 1-23.
20. de Bustros A, Nelkin BD, Silverman A, Ehrlich G, Poiesz B, et al. (1988) The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A 85: 5693-5697.
21. Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, et al. (2011) Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 44: 40-46.
22. Makos M, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM, et al. (1993) DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res 53: 2715-2718.
23. Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, et al. (1993) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 53: 2719-2722.
24. Di Vinci A, Brigati C, Casciano I, Banelli B, Borzi L, et al. (2012) HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas. Transl Res.
25. Kishida Y, Natsume A, Kondo Y, Takeuchi I, An B, et al. (2012) Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. Carcinogenesis 33: 436-441.
26. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
27. Thorvaldsdottir H, Robinson JT, Mesirov JP, (2012) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform.
28. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
29. Baylin SB, Jones PA, (2011) A decade of exploring the cancer epigenome- biological and translational implications. Nat Rev Cancer 11: 726-734.
30. Tsai HC, Baylin SB, (2011) Cancer epigenetics: linking basic biology to clinical medicine. Cell Res 21: 502-517.
31. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
32. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874.
33. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, et al. (2007) Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158.
34. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, et al. (2008) Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 105: 12979-12984.
35. Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, et al. (2010) CpG island hypermethylation in human astrocytomas. Cancer Res 70: 2718-2727.
36. Bestor TH, (2000) The DNA methyltransferases of mammals. Hum Mol Genet 9: 2395-2402.
37. Okano M, Bell DW, Haber DA, Li E, (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
38. Okano M, Xie S, Li E, (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19: 219-220.
39. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee I, et al. (2006) De novo CpG island methylation in human cancer cells. Cancer Res 66: 682-692.
40. Ting AH, Jair KW, Schuebel KE, Baylin SB, (2006) Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. Cancer Res 66: 729-735.
41. Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, et al. (2003) MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene 22: 3463-3471.
42. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, et al. (2011) Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol 12: R83.